Bcl-X(L) is likewise implicated in the pathogenesis of cancer and increased expression is a characteristic of acute myeloid leukemia (AML) and multiple myeloma, as well as solid cancers like bladder cancer, breast cancer, pancreatic cancer and melanoma [13]. Here, BCL2L1 is linked to melanoma.